Molecule’s story starts with patients and researchers. We imagine a world where patients directly fund researchers developing the next therapeutic breakthrough they need. A world where accessible, innovative therapeutics are created through collaborative drug development and fuelled by early R&D funding - operating at the intersection of biotechnology and decentralization, we are building the frameworks and platform to do exactly this.
Over the past 12 months, we have grown our team from 3 to 20 and recently closed a $12.7m Seed round.
Browse, connect and join a team
The decentralized real‑time data network
Simple non-custodial auth infra for Web3 apps and wallets
A global leader in assurance, tax, transaction and advisory services
Web3 made simple just for you
Electric Coin Company
Empower economic freedom
Complete crypto management platform
The video-sharing app for you and your furrend